Drag a card by its title · ⚙ to size, swap or remove
⠿
Who
MCMolly Carr
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, iBio.
⠿
In numbers
- Trades disclosed
- 2
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Jul 2026
- Last trade
- 31 Jul 2026
- Last filed
- 4 Aug 2026
⠿
Companies traded
Where they are an officerIBIO iBioOfficer · Biotechnology · last 31 Jul 20260 buys · 0 sells ⠿
Activity over time
Not enough dated trades to draw.
⠿
Every trade
| Traded | Company | What | Amount | |
|---|
| 31 Jul 2026filed 4 Aug 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —430,000 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —430,000 at $0.00 | filing |
⠿
News
No headline names them, or the companies they trade most, lately.
⠿
Sectors
No trade we could place in a sector.
⠿
Related people
David ArkowitzDirector · Director at iBio, filing Form 4 there in the last year William D. ClarkDirector · Director at iBio, filing Form 4 there in the last year Elizabeth StonerDirector · Director at iBio, filing Form 4 there in the last year Gary SenderDirector · Director at iBio, filing Form 4 there in the last year